WebSep 3, 2012 · September 4, 2012 03:39 IST. Follow Us. Pharma companies marketing ?new drugs? would now have to submit periodic safety profiles of these products to the Drug … WebMay 8, 2024 · Based on these results, Drugs Controller General of India’s (DCGI) Central Drugs Standard Control Organization (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2024. The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in COVID …
Drug Controller General Of India: Latest News, Photos, Videos on …
Web1 day ago · New Delhi: the Drugs Controller General of India (DCGI) cancelled licenses of 18 pharma companies for manufacturing spurious medicines.The decision was take following an inspection by the DCGI on 76 companies across 20 states, ANI said citing sources on Thursday. WebMay 8, 2024 · The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose … gluten induced weakness
Rajeev Raghuvanshi appointed as new Drug Controller General of …
WebJul 13, 2024 · Drugs Controller General of India’s approval of SII’s anti-cervical cancer vaccine follows the recommendation of the institute’s COVID-19 vaccine in June last year July 13, 2024 05:42 am ... http://beta2.zeenews.india.com/india/bharat-biotech-seeks-approval-for-covaxin-booster-trials-for-2-18-age-group-2460554.html WebFeb 22, 2024 · New Delhi: Indian Pharmacopoeia Commission secretary-cum-scientific director Rajeev Singh Raghuvanshiwas on Wednesday … boletas chile